This study will measure ctDNA from older patients with breast cancer.
This is an ongoing prospective cohort study in which we will measure ctDNA specifically from older patients with ER+ breast cancer to monitor treatment response to primary endocrine therapy (the pills you are taking).
We use cookies and other technologies on this website to enhance your user experience. By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.